New evidence regarding the impact of supplementation with PQQ (pyrroloquinoline quinone) appeared this June 2018. Using standard lab animal models, this showed: 1. significant improved cognitive performance; 2. decreased reactive oxygen species; 3. decreased inflammatory markers. Here's the link to the article: https://www.nature.com/articles/s41598-018-26962-9
For more information, contact us at 859-721-1414 or myhealth@prevmedheartrisk.com. Also, check out the following resources: